“…This structural variability occurs as a result of the underlying sequence differences. Most of the bacterial SAICAR synthetase structures exist as a dimer (Ginder et al, 2006;Manjunath et al, 2013;Wolf et al, 2014;Zhang et al, 2006), the structure from yeast and Mycobacterium abscessus is a monomer (Levdikov et al, 1998), and the bifunctional octameric forms are observed only in higher eukaryotes (Li et al, 2007;Taschner et al, 2013). Thus, the structural variations between microbial and human SAICAR synthetase Abbreviations: SAICAR, phosphoribosylaminoimidazole-succinocarboxamide; CAIR, 4-carboxyaminoimidazole ribonucleotide; N 5 -CAIR, N 5 -carboxyaminoimidazole ribonucleotide; ATP, adenosine triphosphate; AMP, adenosine monophosphate; ASP, aspartate; AMP-PNP, adenosine 5 0 -(b,c-imido)tri phosphate; SS, SAICAR synthetase; Ph, Pyrococcus horikoshii; Sc, Saccharomyces cerevisiae; Ec, Escherichia coli; Sp, Streptococcus pneumoniae.…”